Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT05178810 · COMPLETED
Trial details
- NCT number
- NCT05178810
- Sponsor
- Ferrer Internacional S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2023-10-26
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.